ASCO GUIDELINES Bundle

Estrogen and Progesterone Receptor Testing in Breast Cancer

ASCO GUIDELINES App Bundle brought to you fcourtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1199868

Contents of this Issue

Navigation

Page 12 of 13

13 Figure 4. External Controls A B C Figure legend: Optimal external (ideally on-slide) controls for both ER and PgR should include multiple tissues including ones with expected strong staining, lower limit of detection levels and negative controls; tonsil and cervix have been used to meet these criteria. Panel A (200x) shows tonsil tissue with optimal staining for ER to ensure an appropriate low limit of detection; dispersed germinal center cells and the squamous epithelium should be ER positive but the B-cells in the mantle zones should be ER negative. In contrast to ER, no nuclear PgR staining should be seen in tonsillar tissue. Weak positive PgR staining in tonsil should result in work-up to determine if assay dri has occurred. Panel B (200×) shows PgR variably staining the basal layer of the squamous mucosa as expected (this staining should ensure an appropriate low limit of detection for PgR). Stromal cells stain strongly for both ER and PgR. ER should stain the squamous mucosa more uniformly (not just the basal layer) with at least moderate to strong stain intensity. Panel C (200×) shows PgR staining should also be positive in the endocervical columnar epithelial cells (with some variability expected). ER should stain almost all endocervical columnar epithelial cells. Of note, it should be taken into consideration that hormone receptor staining of cervical tissue may be reduced in tissue from post- menopausal women.

Articles in this issue

Archives of this issue

view archives of ASCO GUIDELINES Bundle - Estrogen and Progesterone Receptor Testing in Breast Cancer